Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-29

FDA Approved: GLIMEPIRIDE — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved the original ANDA for glimepiride manufactured by Micro Labs Limited, a generic drug for type 2 diabetes mellitus to improve glycemic control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

ORIG AP for GLIMEPIRIDE (GLIMEPIRIDE)